Associate Director, Biosimilars and Therapeutic Biologics
US Food and Drug Administration
Dr. Yow-Ming Wang is currently the Associate Director for Biosimilars and Therapeutic Biologics and leading Therapeutic Biologics Program in the Office of Clinical Pharmacology at the FDA. From 2011 to September 2017, Dr. Wang served as the team leader of Biologics Team in Division of Clinical Pharmacology III; her team was responsible for reviewing submissions of therapeutic biologics for dermatology, gastroenterology, bone health, in-born error of metabolism, reproductive and urologic indications, etc., in three clinical divisions. Prior to joining the FDA, she worked in the pharmaceutical industry with experience in small molecules and large molecules. From 2004 to 2011, she worked at Amgen where she supported multiple biologic products in preclinical and clinical development, in registration phase, and in post-marketing phase. Before Amgen, she supported small molecule drug discovery and development for 11 years at Vertex Pharmaceuticals and at Parke-Davis Pharmaceutical Research. She received her PhD degree from The Ohio State University College of Pharmacy with a research focus on Pharmacokinetics and Biopharmaceutics.
Disclosure information not submitted.
Wednesday, January 12, 2022
3:30 PM – 4:30 PM ET
.png)